Building Blocks

Please enquire for more information about Coproporphyrin III including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 4-Chloro-N-[2-(1,2-dihydro-2-oxo-4-quinolinyl)ethyl]benzamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about (αR)-α-(2-Chlorophenyl)-2H-tetrazole-2-ethanol  including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about D-Carnosine trifluoroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-Chlorobenzenethiol is a chemical compound that contains a fatty acid. It is an intramolecular hydrogen donor with the ability to form a disulfide bond. The compound also has high stability and can be used in organic synthesis reactions involving reactive sulfur groups. 4-Chlorobenzenethiol reacts with sodium carbonate to produce sodium thiocarbonate and chloroform, which are then reacted with phosphorus pentoxide for oxidation. The reaction mechanism is similar to that of the Diels-Alder reaction and the model system involves dinucleotide phosphate. 4-Chlorobenzenethiol can be reacted with hydrochloric acid or trifluoroacetic acid as an oxidizing agent.

1,1'-Carbonimidoylbis-1H-imidazole is a ligand that binds to amines and isosteres. It can be activated with electrophilic reagents to form an activated linker. This ligand has been shown to inhibit the growth of xenograft tumor cells in mice by binding to functional groups on the cell surface. This drug also has been shown to bind to the receptor for advanced glycation end products (RAGE) and inhibit its function. 1,1'-Carbonimidoylbis-1H-imidazole has also been evaluated as a cancer therapeutic agent in animal models.

2-Chloro-3-(hydroxymethyl)pyridine is an organic compound that is used as a building block for the synthesis of other heterocycles. This compound can be synthesized from 2-chloronicotinic acid, which is obtained by oxidation of nicotine with sodium hypochlorite in the presence of potassium ion. The reaction proceeds via a cleavage of the C-Cl bond and formation of a pyridine ring. The catalytic process can be performed at room temperature and at atmospheric pressure in a variety of solvents, including water.
2-Chloro-3-(hydroxymethyl)pyridine has been shown to have high yields for the preparation of compounds such as 2,4-dichloropyridine and 4,5-dichloropyrimidine. It also has been used in the preparation of pharmaceuticals such as atrial natriuretic factor (ANF).

2,5-Dibromo-3-aminopyrazine is an experimental drug with anticancer activity. It has been shown to have a high affinity for DNA and inhibit the growth of tumor cells in vivo. 2,5-Dibromo-3-aminopyrazine has undergone stability tests in vivo and in vitro and also completed clinical trials. This drug binds to DNA and inhibits the enzyme protein kinase C, leading to suppression of cellular proliferation. The pharmacokinetics of this drug were evaluated by measuring the concentration of 2,5-dibromo-3-aminopyrazine in plasma after oral administration to mice. This study found that the maximum concentration was achieved at 1 hour post dose and that there was a decrease in concentration over time. The drug has been shown to bind to the dimethoxybenzene metabolic pathway, which is involved in regulating cell proliferation.
2,5-Dibromo-3-aminopyrazine

2,4-Dibromopyridine is a brominated derivative of pyridine. It is synthesized through the substitution of two bromine atoms for two hydrogens on the pyridine ring. This synthesis can be achieved by disubstitution or cross-coupling reactions. The reaction products are nucleophilic and react with electrophiles to produce substitution products. The reaction mechanism is thought to involve a six-membered transition state, which has been observed using X-ray absorption spectroscopy.

3,5-Dimethyl-4H-1,2,4-triazol-4-amine is a crystalline compound with antiproliferative and anti-inflammatory properties. It has been shown to inhibit the growth of cancer cells in vitro and in vivo. The mechanism of action is not fully understood but may be due to inhibition of DNA synthesis or by inhibiting the activity of topoisomerase II. 3,5-Dimethyl-4H-1,2,4-triazol-4-amine can also act as an antioxidant by scavenging reactive oxygen species (ROS). 3,5-Dimethyl-4H-1,2,4-triazol-4-amine has been shown to have a low toxicity in animals and humans.